What Does Full Approval of Pfizer’s COVID-19 Vaccine Mean?

On Aug. 23, the FDA gave full approval to the Pfizer/BioNTech COVID-19 vaccine for people 16 and older. Since last December, nearly 202 million Americans have received at least one dose of a vaccine, including the two-dose vaccines made by Pfizer/BioNTech and Moderna, and Johnson & Johnson’s single-dose vaccine. In recent months, the pace of vaccinations has slowed even as the delta variant is causing a new wave of cases, hospitalizations and deaths. But the FDA’s endorsement of the Pfizer/BioNTech vaccine may convince more unvaccinated people to get their shot and clear the way for more employers to impose vaccine mandates. A recent poll from the Kaiser Family Foundation found that 31% of unvaccinated people would be more likely to get their shots if the vaccine gets full approval.

© 2022 MMIT
Jinghong Chen

Jinghong Chen Reporter

Jinghong produces infographics and data stories on health insurance and specialty pharmacy for AIS Health. She graduated from Missouri School of Journalism with a focus on data journalism and international reporting. Before joining AIS in 2018, she worked at WBEZ, Al Jazeera English and The New York Times Chinese.

Related Posts

pills
September 22

Report Shows Limited Access to Opioid Use Disorder Treatments for Medicare Beneficiaries

READ MORE
cms-website
September 22

Drug Price Negotiation Will Require New CMS Regulations, Staffing

READ MORE
fda-sign
September 22

Accelerated Approval Prices Are Unrelated to Clinical Value, Study Says

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today